Clinical trial
Hypofractionated Radiotherapy for Lung Cancer
NCT00214123 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00214123 |
|---|---|
| Title | Hypofractionated Radiotherapy for Lung Cancer |
| Official title | The Use of Helical Tomotherapy to Achieve Dose-per-fraction Escalation in Lung Cancer |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Radiation |
| Interventions | radiation therapy (radiotherapy) |
| Enrollment | 79 |
| Start date | Jun 1, 2004 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Sep 21, 2005 |
| Last update posted | Dec 13, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: